INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

(2018) Heinz Läubli et al.   Journal for ImmunoTherapy of Cancer

Assessment of cancer and virus antigens for cross-reactivity in human tissues

(2016) Victor Jaravine et al.   BIOINFORMATICS

Coley’s Lessons Remembered

(2016) Maurice Orange et al.   INTEGRATIVE CANCER THERAPIES

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)

(2014) P. Pedrazzoli et al.   ANNALS OF ONCOLOGY

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2013) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Local Blockade of Epithelial PDL-1 in the Airways Enhances T Cell Function and Viral Clearance during Influenza Virus Infection

(2013) Beth McNally et al.   JOURNAL OF VIROLOGY

Clearance of influenza virus infections by T cells: risk of collateral damage?

(2013) MLB Hillaire et al.   Current Opinion in Virology

Estimating influenza incidence and rates of influenza-like illness in the outpatient setting

(2012) Ashley Fowlkes et al.   Influenza and Other Respiratory Viruses

Viral acute lower respiratory infections impair CD8+ T cells through PD-1

(2012) John J. Erickson et al.   JOURNAL OF CLINICAL INVESTIGATION

Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology

(2012) C. R. Beck et al.   JOURNAL OF INFECTIOUS DISEASES

Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients With Advanced Melanoma

(2011) Jeffrey S. Weber et al.   JOURNAL OF IMMUNOTHERAPY

Interference with Intraepithelial TNF-α Signaling Inhibits CD8+ T-Cell-Mediated Lung Injury in Influenza Infection

(2010) Anon Srikiatkhachorn et al.   VIRAL IMMUNOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER